Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox in mild to moderate acne vulgaris
NCT00765375Phase 2Terminated
- Sponsor
- DeNova Research
- Start
- Sep 2008
- Primary completion
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of botulinum toxin type A in acne vulgaris, sponsored by DeNova Research. Primary endpoint: Change in Mean Lesion Count From Baseline at 90 Days. Started Sep 2008; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00765375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00765375.